Tag: Fasinumab
Teva, Regeneron report positive data for fasinumab in phase 3 osteoarthritis trial
Teva Pharmaceutical Industries and Regeneron Pharmaceuticals said that a phase 3 study evaluating nerve growth factor (NGF) antibody fasinumab in patients with chronic pain from ... Read More